Nisa Investment Advisors
TEVA icon

Nisa Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Nisa Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680K Buy
20,073
+5,948
+42% +$198K ﹤0.01% 896
2026
Q1 		$425K Buy
14,125
+941
+7% +$30.3K ﹤0.01% 1008
2025
Q4 		$411K Buy
+13,184
New +$325K ﹤0.01% 1059
2023
Q2 		– Sell
-15,890
Closed -$141K – 2869
2023
Q1 		$141K Buy
15,890
+774
+5% +$7.65K ﹤0.01% 1389
2022
Q4 		$138K Sell
15,116
-10,712
-41% -$93.5K ﹤0.01% 1455
2022
Q3 		$208K Sell
25,828
-96,023
-79% -$849K ﹤0.01% 1264
2022
Q2 		$916K Buy
121,851
+35,968
+42% +$313K 0.01% 850
2022
Q1 		$806K Sell
85,883
-8,252
-9% -$68.9K 0.01% 941
2021
Q4 		$794K Buy
+94,135
New +$850K 0.01% 895
2021
Q2 		– Sell
-23,340
Closed -$269K – 2384
2021
Q1 		$269K Buy
+23,340
New +$268K ﹤0.01% 1383
2020
Q3 		– Sell
-74,443
Closed -$918K – 2266
2020
Q2 		$918K Buy
+74,443
New +$842K 0.01% 814
2019
Q3 		– Sell
-126
Closed -$1K – 2045
2019
Q2 		$1K Sell
126
-247
-66% -$2.98K ﹤0.01% 2008
2019
Q1 		$6K Sell
373
-19,020
-98% -$335K ﹤0.01% 1878
2018
Q4 		$299K Sell
19,393
-3,900
-17% -$80K ﹤0.01% 1137
2018
Q3 		$504K Buy
23,293
+22,920
+6,145% +$532K ﹤0.01% 1091
2018
Q2 		$11K Sell
373
-101
-21% -$2.06K ﹤0.01% 1712
2018
Q1 		$13K Hold
474
– – ﹤0.01% 1579
2017
Q4 		$13K Hold
474
– – ﹤0.01% 1680
2017
Q3 		$14K Buy
474
+3
+0.6% +$68 ﹤0.01% 1643
2017
Q2 		$17K Sell
471
-206
-30% -$6.38K ﹤0.01% 1534
2017
Q1 		$25K Hold
677
– – ﹤0.01% 1477
2016
Q4 		$25K Hold
677
– – ﹤0.01% 1569
2016
Q3 		$31K Sell
677
-34
-5% -$1.77K ﹤0.01% 1509
2016
Q2 		$37K Buy
711
+88
+14% +$4.68K ﹤0.01% 1435
2016
Q1 		$33K Buy
+623
New +$36.6K ﹤0.01% 1457

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Nisa Investment Advisors's TEVA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Teva Pharmaceuticals (TEVA) stake by 42% in Q2 2026, buying an estimated $198K and bringing the position to 20,073 shares worth $680K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Nisa Investment Advisors first reported a position in TEVA in Q1 2016 and has held it in 25 quarters since. The position peaked at $918K in Q2 2020. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Nisa Investment Advisors held 20,073 shares of Teva Pharmaceuticals worth $680K as of Q2 2026.
  • Nisa Investment Advisors bought 5,948 Teva Pharmaceuticals shares in Q2 2026, an estimated $198K.
  • Teva Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #896 holding.
  • Nisa Investment Advisors first reported a position in Teva Pharmaceuticals in Q1 2016 and has held it in 25 quarters since.
  • Nisa Investment Advisors's Teva Pharmaceuticals position peaked at $918K in Q2 2020.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.